Non Invasive In Vivo Monitoring Of Dimethyl Fumarate Treatment In Eae By Assessing The Glucose Metabolism In Secondary Lymphoid Organs

[F-18]FDG-PET/CT is a high sensitive functional diagnostic imaging modality to monitor tumor but also immune cell activation by determination of the glucose metabolism. Our results show that the anti-inflammatory effects of immunotherapeutics like DMF can be assessed non invasively in vivo during Th1/Th17 cell-mediated encephalomyelitis (EAE) by [F-18]FDG-PET/CT imaging of the draining lymph nodes.